Monograph Details
|
|
Ob/Gyn
> Contraception
|
|
PARAGARD T380A |
| Manufacturer |
|
Duramed Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
IUD. |
| Generic Name |
|
Copper-bearing intrauterine contraceptive device. |
| Indications |
|
Intrauterine contraception. |
| Children |
|
<16yrs: not recommended. |
| Adults |
|
See literature. ≥16yrs: Insert into uterine cavity. Check placement shortly after first menses. Replace at least every 10 years. |
| Contraindications |
|
Uterine abnormality. Uterine or cervical malignancy. Pelvic inflammatory disease or risk thereof. Postpartum or postabortal endometritis in the past 3 months. Genital actinomycosis. Abnormal genital bleeding. Cervicitis. Wilson's disease. Retained IUD. Pregnancy or suspicion of pregnancy. |
| Precautions |
|
Vaginal bleeding. Ectopic pregnancy. Immunocompromised. Immunosuppressive therapy. Avoid medical diathermy. Assure suitable uterine anatomy before insertion. Remove the device if evidence of partial expulsion, perforation, or breakage. |
| Adverse Reactions |
|
Bleeding, cramps, anemia, dyspareunia, pelvic infection, infertility, ectopic pregnancy, uterine or cervical perforation, embedment or fragmentation of device, septicemia (during pregnancy), spontaneous abortion, vasovagal reactions (during insertion or removal). |
| How Supplied |
|
Device—1, 5 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
